Editorial: Genome editing applications of CRISPR/Cas9 in metabolic diseases, hormonal system and cancer research.
Frontiers in endocrinology, 14: 1256966 PMID 37608792 DOI 10.3389/fendo.2023.1256966
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.